{"id":"https://openalex.org/W2005444614","doi":"https://doi.org/10.1007/s00277-012-1482-6","title":"Visceral leishmaniasis infection in a refractory multiple myeloma patient treated with bortezomib","display_name":"Visceral leishmaniasis infection in a refractory multiple myeloma patient treated with bortezomib","alternate_titles":[],"publication_year":2012,"publication_date":"2012-05-14","ids":{"openalex":"https://openalex.org/W2005444614","doi":"https://doi.org/10.1007/s00277-012-1482-6","mag":"2005444614","pmid":"https://pubmed.ncbi.nlm.nih.gov/22584850"},"language":"en","primary_location":{"id":"doi:10.1007/s00277-012-1482-6","doi":"https://doi.org/10.1007/s00277-012-1482-6","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s00277-012-1482-6","pdf_url":null,"source":{"id":"https://openalex.org/S163204731","display_name":"Annals of Hematology","issn_l":"0939-5555","issn":["0939-5555","1432-0584"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Hematology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2005444614"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5042005810","display_name":"Eugenio Piro","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148440","display_name":"Azienda Ospedaliera Pugliese Ciaccio","ror":"https://ror.org/053y0qd29","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210148440"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Eugenio Piro","raw_affiliation_strings":["Department of Oncology and Hematology, Azienda Ospedaliera Pugliese-Ciaccio, Viale Pio X, 88100, Catanzaro, Italy","Department of Oncology and Hematology, Azienda Ospedaliera Pugliese-Ciaccio, Catanzaro, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology and Hematology, Azienda Ospedaliera Pugliese-Ciaccio, Viale Pio X, 88100, Catanzaro, Italy","institution_ids":["https://openalex.org/I4210148440"]},{"raw_affiliation_string":"Department of Oncology and Hematology, Azienda Ospedaliera Pugliese-Ciaccio, Catanzaro, Italy","institution_ids":["https://openalex.org/I4210148440"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037093863","display_name":"Mariagrazia Kropp","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148440","display_name":"Azienda Ospedaliera Pugliese Ciaccio","ror":"https://ror.org/053y0qd29","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210148440"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Mariagrazia Kropp","raw_affiliation_strings":["Department of Oncology and Hematology, Azienda Ospedaliera Pugliese-Ciaccio, Viale Pio X, 88100, Catanzaro, Italy","Department of Oncology and Hematology, Azienda Ospedaliera Pugliese-Ciaccio, Catanzaro, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology and Hematology, Azienda Ospedaliera Pugliese-Ciaccio, Viale Pio X, 88100, Catanzaro, Italy","institution_ids":["https://openalex.org/I4210148440"]},{"raw_affiliation_string":"Department of Oncology and Hematology, Azienda Ospedaliera Pugliese-Ciaccio, Catanzaro, Italy","institution_ids":["https://openalex.org/I4210148440"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062325158","display_name":"Renato Cantaffa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148440","display_name":"Azienda Ospedaliera Pugliese Ciaccio","ror":"https://ror.org/053y0qd29","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210148440"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Renato Cantaffa","raw_affiliation_strings":["Department of Oncology and Hematology, Azienda Ospedaliera Pugliese-Ciaccio, Viale Pio X, 88100, Catanzaro, Italy","Department of Oncology and Hematology, Azienda Ospedaliera Pugliese-Ciaccio, Catanzaro, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology and Hematology, Azienda Ospedaliera Pugliese-Ciaccio, Viale Pio X, 88100, Catanzaro, Italy","institution_ids":["https://openalex.org/I4210148440"]},{"raw_affiliation_string":"Department of Oncology and Hematology, Azienda Ospedaliera Pugliese-Ciaccio, Catanzaro, Italy","institution_ids":["https://openalex.org/I4210148440"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022144997","display_name":"Angelo Giuseppe Lamberti","orcid":"https://orcid.org/0000-0002-5934-8322","observed_orcids":["https://orcid.org/0000-0002-5934-8322"]},"institutions":[{"id":"https://openalex.org/I4210148440","display_name":"Azienda Ospedaliera Pugliese Ciaccio","ror":"https://ror.org/053y0qd29","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210148440"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Angelo Giuseppe Lamberti","raw_affiliation_strings":["Department of Oncology and Hematology, Azienda Ospedaliera Pugliese-Ciaccio, Viale Pio X, 88100, Catanzaro, Italy","Department of Oncology and Hematology, Azienda Ospedaliera Pugliese-Ciaccio, Catanzaro, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology and Hematology, Azienda Ospedaliera Pugliese-Ciaccio, Viale Pio X, 88100, Catanzaro, Italy","institution_ids":["https://openalex.org/I4210148440"]},{"raw_affiliation_string":"Department of Oncology and Hematology, Azienda Ospedaliera Pugliese-Ciaccio, Catanzaro, Italy","institution_ids":["https://openalex.org/I4210148440"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015965477","display_name":"Guido Carillio","orcid":"https://orcid.org/0000-0002-7652-9432","observed_orcids":["https://orcid.org/0000-0002-7652-9432"]},"institutions":[{"id":"https://openalex.org/I4210148440","display_name":"Azienda Ospedaliera Pugliese Ciaccio","ror":"https://ror.org/053y0qd29","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210148440"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Guido Carillio","raw_affiliation_strings":["Department of Oncology and Hematology, Azienda Ospedaliera Pugliese-Ciaccio, Viale Pio X, 88100, Catanzaro, Italy","Department of Oncology and Hematology, Azienda Ospedaliera Pugliese-Ciaccio, Catanzaro, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology and Hematology, Azienda Ospedaliera Pugliese-Ciaccio, Viale Pio X, 88100, Catanzaro, Italy","institution_ids":["https://openalex.org/I4210148440"]},{"raw_affiliation_string":"Department of Oncology and Hematology, Azienda Ospedaliera Pugliese-Ciaccio, Catanzaro, Italy","institution_ids":["https://openalex.org/I4210148440"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061896020","display_name":"Stefano Molica","orcid":"https://orcid.org/0000-0003-2795-6507","observed_orcids":["https://orcid.org/0000-0003-2795-6507"]},"institutions":[{"id":"https://openalex.org/I4210148440","display_name":"Azienda Ospedaliera Pugliese Ciaccio","ror":"https://ror.org/053y0qd29","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210148440"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Stefano Molica","raw_affiliation_strings":["Department of Oncology and Hematology, Azienda Ospedaliera Pugliese-Ciaccio, Viale Pio X, 88100, Catanzaro, Italy","Department of Oncology and Hematology, Azienda Ospedaliera Pugliese-Ciaccio, Catanzaro, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology and Hematology, Azienda Ospedaliera Pugliese-Ciaccio, Viale Pio X, 88100, Catanzaro, Italy","institution_ids":["https://openalex.org/I4210148440"]},{"raw_affiliation_string":"Department of Oncology and Hematology, Azienda Ospedaliera Pugliese-Ciaccio, Catanzaro, Italy","institution_ids":["https://openalex.org/I4210148440"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5015965477"],"corresponding_institution_ids":["https://openalex.org/I4210148440"],"apc_list":{"value":4590,"currency":"USD","value_usd":4590},"apc_paid":null,"fwci":1.5288,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.82402988,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"91","issue":"11","first_page":"1827","last_page":"1828"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10823","display_name":"Research on Leishmaniasis Studies","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10823","display_name":"Research on Leishmaniasis Studies","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.006599999964237213,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11909","display_name":"Histiocytic Disorders and Treatments","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/visceral-leishmaniasis","display_name":"visceral leishmaniasis","score":1.0},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9760000109672546},{"id":"https://openalex.org/keywords/bortezomib","display_name":"bortezomib","score":0.9229999780654907},{"id":"https://openalex.org/keywords/drug-induced-infection","display_name":"drug-induced infection","score":0.7139999866485596},{"id":"https://openalex.org/keywords/refractory-multiple-myeloma","display_name":"refractory multiple myeloma","score":0.75},{"id":"https://openalex.org/keywords/opportunistic-infections","display_name":"opportunistic infections","score":0.6899999976158142},{"id":"https://openalex.org/keywords/immunosuppression","display_name":"immunosuppression","score":0.7400000095367432}],"concepts":[{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.8644436001777649},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.7845439910888672},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7718439698219299},{"id":"https://openalex.org/C194409129","wikidata":"https://www.wikidata.org/wiki/Q103824","display_name":"Hematology","level":2,"score":0.7615611553192139},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5998777747154236},{"id":"https://openalex.org/C2778689377","wikidata":"https://www.wikidata.org/wiki/Q2046113","display_name":"Visceral leishmaniasis","level":3,"score":0.5849478840827942},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.5566530823707581},{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.5352023243904114},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3940192461013794},{"id":"https://openalex.org/C2776555147","wikidata":"https://www.wikidata.org/wiki/Q331283","display_name":"Leishmaniasis","level":2,"score":0.3234441876411438},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2620928883552551},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000069286","descriptor_name":"Bortezomib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000981","descriptor_name":"Antiprotozoal Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001854","descriptor_name":"Bone Marrow Cells","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001854","descriptor_name":"Bone Marrow Cells","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D001854","descriptor_name":"Bone Marrow Cells","qualifier_ui":"Q000469","qualifier_name":"parasitology","is_major_topic":false},{"descriptor_ui":"D001854","descriptor_name":"Bone Marrow Cells","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D001897","descriptor_name":"Boronic Acids","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001897","descriptor_name":"Boronic Acids","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007558","descriptor_name":"Italy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007893","descriptor_name":"Leishmania donovani","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D007893","descriptor_name":"Leishmania donovani","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":false},{"descriptor_ui":"D007898","descriptor_name":"Leishmaniasis, Visceral","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D007898","descriptor_name":"Leishmaniasis, Visceral","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D007898","descriptor_name":"Leishmaniasis, Visceral","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D007898","descriptor_name":"Leishmaniasis, Visceral","qualifier_ui":"Q000469","qualifier_name":"parasitology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D009894","descriptor_name":"Opportunistic Infections","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D009894","descriptor_name":"Opportunistic Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009894","descriptor_name":"Opportunistic Infections","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D009894","descriptor_name":"Opportunistic Infections","qualifier_ui":"Q000469","qualifier_name":"parasitology","is_major_topic":false},{"descriptor_ui":"D011719","descriptor_name":"Pyrazines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011719","descriptor_name":"Pyrazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D061988","descriptor_name":"Proteasome Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D061988","descriptor_name":"Proteasome Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1007/s00277-012-1482-6","doi":"https://doi.org/10.1007/s00277-012-1482-6","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s00277-012-1482-6","pdf_url":null,"source":{"id":"https://openalex.org/S163204731","display_name":"Annals of Hematology","issn_l":"0939-5555","issn":["0939-5555","1432-0584"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Hematology","raw_type":"journal-article"},{"id":"pmid:22584850","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22584850","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of hematology","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":10,"referenced_works":["https://openalex.org/W1978643311","https://openalex.org/W1991591667","https://openalex.org/W2004739024","https://openalex.org/W2088556174","https://openalex.org/W2096840509","https://openalex.org/W2114204948","https://openalex.org/W2126690433","https://openalex.org/W2136727321","https://openalex.org/W2159195400","https://openalex.org/W2170956456"],"related_works":["https://openalex.org/W1444719329","https://openalex.org/W1994880815","https://openalex.org/W4400828945","https://openalex.org/W2112940708","https://openalex.org/W3184554940","https://openalex.org/W4396927294","https://openalex.org/W4285793078","https://openalex.org/W2085145014","https://openalex.org/W3110940055","https://openalex.org/W2535024485"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2005444614","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-13T13:42:25.865203","created_date":"2016-06-24T00:00:00"}
